DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 97 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $35,278,000 | -8.8% | 2,456,669 | 0.0% | 2.10% | +1.2% |
| Q2 2019 | $38,693,000 | +7.5% | 2,456,669 | 0.0% | 2.08% | +33.8% |
| Q1 2019 | $35,990,000 | +37.0% | 2,456,669 | 0.0% | 1.55% | +1.5% |
| Q4 2018 | $26,262,000 | -56.2% | 2,456,669 | -37.5% | 1.53% | -52.4% |
| Q3 2018 | $60,025,000 | +24.6% | 3,933,489 | 0.0% | 3.21% | +2.6% |
| Q2 2018 | $48,185,000 | +28.1% | 3,933,489 | 0.0% | 3.13% | +8.6% |
| Q1 2018 | $37,604,000 | -16.1% | 3,933,489 | -20.8% | 2.88% | -23.2% |
| Q4 2017 | $44,839,000 | +221.1% | 4,965,513 | +104.5% | 3.75% | +197.3% |
| Q3 2017 | $13,964,000 | +81.4% | 2,428,571 | 0.0% | 1.26% | +42.9% |
| Q2 2017 | $7,699,000 | -6.8% | 2,428,571 | 0.0% | 0.88% | -12.8% |
| Q1 2017 | $8,257,000 | +18.1% | 2,428,571 | 0.0% | 1.01% | +2.2% |
| Q4 2016 | $6,994,000 | -51.0% | 2,428,571 | 0.0% | 0.99% | -32.7% |
| Q3 2016 | $14,280,000 | +96.0% | 2,428,571 | 0.0% | 1.47% | +46.0% |
| Q2 2016 | $7,286,000 | -44.0% | 2,428,571 | 0.0% | 1.01% | -39.4% |
| Q1 2016 | $13,017,000 | -54.8% | 2,428,571 | 0.0% | 1.66% | -41.7% |
| Q4 2015 | $28,827,000 | +44.6% | 2,428,571 | 0.0% | 2.85% | -0.4% |
| Q3 2015 | $19,939,000 | -41.1% | 2,428,571 | 0.0% | 2.86% | -16.0% |
| Q2 2015 | $33,879,000 | -41.9% | 2,428,571 | 0.0% | 3.41% | -41.2% |
| Q1 2015 | $58,359,000 | +45.9% | 2,428,571 | 0.0% | 5.80% | +34.8% |
| Q4 2014 | $39,999,000 | +29.4% | 2,428,571 | 0.0% | 4.30% | +17.7% |
| Q3 2014 | $30,916,000 | -43.6% | 2,428,571 | 0.0% | 3.65% | -34.1% |
| Q2 2014 | $54,813,000 | -20.1% | 2,428,571 | 0.0% | 5.54% | +12.6% |
| Q1 2014 | $68,607,000 | – | 2,428,571 | – | 4.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |